FGF19 and head and neck squamous cell carcinoma: Results obtained demonstrate the impact of MT dosages on HNSCC malignancy, suggesting inhibition of FGF19-FGFR signaling axis to be a potential strategy for improving the therapeutic efficacy of MT supplements.